DE602007010969D1 - Zytokinderivate - Google Patents

Zytokinderivate

Info

Publication number
DE602007010969D1
DE602007010969D1 DE602007010969T DE602007010969T DE602007010969D1 DE 602007010969 D1 DE602007010969 D1 DE 602007010969D1 DE 602007010969 T DE602007010969 T DE 602007010969T DE 602007010969 T DE602007010969 T DE 602007010969T DE 602007010969 D1 DE602007010969 D1 DE 602007010969D1
Authority
DE
Germany
Prior art keywords
terminal portion
zytokinderivate
polypeptides
seq
amino acid
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Active
Application number
DE602007010969T
Other languages
English (en)
Inventor
Oliver Hartley
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Mintaka Foundation for Medical Res
Original Assignee
Mintaka Foundation for Medical Res
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Mintaka Foundation for Medical Res filed Critical Mintaka Foundation for Medical Res
Publication of DE602007010969D1 publication Critical patent/DE602007010969D1/de
Active legal-status Critical Current
Anticipated expiration legal-status Critical

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/52—Cytokines; Lymphokines; Interferons
    • C07K14/521—Chemokines
    • C07K14/523—Beta-chemokines, e.g. RANTES, I-309/TCA-3, MIP-1alpha, MIP-1beta/ACT-2/LD78/SCIF, MCP-1/MCAF, MCP-2, MCP-3, LDCF-1, LDCF-2
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • A61K38/19—Cytokines; Lymphokines; Interferons
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A61P11/06—Antiasthmatics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00—Drugs for skeletal disorders
    • A61P19/02—Drugs for skeletal disorders for joint disorders, e.g. arthritis, arthrosis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/02—Drugs for disorders of the nervous system for peripheral neuropathies
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P27/00—Drugs for disorders of the senses
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A61P31/14—Antivirals for RNA viruses
    • A61P31/18—Antivirals for RNA viruses for HIV
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A61P35/04—Antineoplastic agents specific for metastasis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/02—Immunomodulators
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/02—Immunomodulators
    • A61P37/04—Immunostimulants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/02—Immunomodulators
    • A61P37/06—Immunosuppressants, e.g. drugs for graft rejection
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/08—Antiallergic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/52—Cytokines; Lymphokines; Interferons

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Immunology (AREA)
  • Molecular Biology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Zoology (AREA)
  • Biophysics (AREA)
  • Biochemistry (AREA)
  • Genetics & Genomics (AREA)
  • Toxicology (AREA)
  • Pulmonology (AREA)
  • Oncology (AREA)
  • Neurosurgery (AREA)
  • Communicable Diseases (AREA)
  • Rheumatology (AREA)
  • Virology (AREA)
  • Biomedical Technology (AREA)
  • Neurology (AREA)
  • Pain & Pain Management (AREA)
  • Vascular Medicine (AREA)
  • Orthopedic Medicine & Surgery (AREA)
  • Dermatology (AREA)
  • AIDS & HIV (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Epidemiology (AREA)
  • Transplantation (AREA)
DE602007010969T 2006-07-25 2007-07-25 Zytokinderivate Active DE602007010969D1 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
GBGB0614755.7A GB0614755D0 (en) 2006-07-25 2006-07-25 Cytokine derivatives
PCT/IB2007/003026 WO2008012689A2 (en) 2006-07-25 2007-07-25 Cytokine derivatives

Publications (1)

Publication Number Publication Date
DE602007010969D1 true DE602007010969D1 (de) 2011-01-13

Family

ID=37006114

Family Applications (1)

Application Number Title Priority Date Filing Date
DE602007010969T Active DE602007010969D1 (de) 2006-07-25 2007-07-25 Zytokinderivate

Country Status (26)

Country Link
US (2) US8686111B2 (de)
EP (1) EP2076532B1 (de)
JP (1) JP5224603B2 (de)
KR (1) KR101530353B1 (de)
CN (1) CN101511867B (de)
AT (1) ATE490270T1 (de)
AU (1) AU2007278894B2 (de)
BR (1) BRPI0715331B8 (de)
CA (1) CA2658806C (de)
CY (1) CY1111630T1 (de)
DE (1) DE602007010969D1 (de)
DK (1) DK2076532T3 (de)
ES (1) ES2361455T3 (de)
GB (1) GB0614755D0 (de)
HK (1) HK1131162A1 (de)
HR (1) HRP20110146T1 (de)
ME (1) ME01320B (de)
MX (1) MX2009000918A (de)
NZ (1) NZ575092A (de)
PL (1) PL2076532T3 (de)
PT (1) PT2076532E (de)
RS (1) RS51854B (de)
RU (1) RU2461567C2 (de)
SI (1) SI2076532T1 (de)
WO (1) WO2008012689A2 (de)
ZA (1) ZA200901342B (de)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
IT201600091033A1 (it) * 2016-09-08 2018-03-08 Bioimmunizer Sagl Ceppi di batteri probiotici appartenenti al genere Bifidobacterium e loro estratti di cellule probiotiche (ECP) aventi proprietà immunostimolanti.
CA3101556A1 (en) * 2018-05-28 2019-12-05 ORION Biotechnology Switzerland Sarl Ccr5 inhibitor for use in treating cancer
CN112469430A (zh) * 2018-05-28 2021-03-09 日内瓦大学 抑制大脑炎症的方法

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN1111540C (zh) * 1993-06-09 2003-06-18 康诺特实验室有限公司 串联的合成hiv－1肽类
FR2748938B1 (fr) * 1996-05-22 1998-07-31 Pasteur Institut Utilisation de molecules antagonistes de chemokines pour leur activite antivirale notamment contre un retrovirus de type vih
UA77950C2 (en) 2000-10-04 2007-02-15 Applied Research Systems Use of mutants of cc chemokines for treatment of multiple sclerosis
US20030049603A1 (en) * 2001-09-05 2003-03-13 Guy Gorochov Methods for construction and screening of libraries of chemokine variants
US7442512B2 (en) * 2001-11-30 2008-10-28 Chemocentryx, Inc. Compositions and methods for detecting and treating diseases and conditions related to chemokine receptors
WO2005112567A2 (en) 2004-05-03 2005-12-01 University Of Maryland Biotechnology Institute Vaginal microbicide

Also Published As

Publication number Publication date
MX2009000918A (es) 2009-08-26
CN101511867B (zh) 2014-04-09
US9328153B2 (en) 2016-05-03
EP2076532A2 (de) 2009-07-08
JP5224603B2 (ja) 2013-07-03
DK2076532T3 (da) 2011-03-07
ATE490270T1 (de) 2010-12-15
CN101511867A (zh) 2009-08-19
US20130330305A1 (en) 2013-12-12
ME01320B (me) 2013-12-20
ES2361455T3 (es) 2011-06-17
BRPI0715331A2 (pt) 2013-07-16
NZ575092A (en) 2011-08-26
WO2008012689A3 (en) 2008-05-08
US20090317363A1 (en) 2009-12-24
AU2007278894B2 (en) 2012-08-09
WO2008012689A2 (en) 2008-01-31
BRPI0715331B1 (pt) 2021-04-13
US8686111B2 (en) 2014-04-01
PT2076532E (pt) 2011-03-02
RU2461567C2 (ru) 2012-09-20
JP2009544304A (ja) 2009-12-17
EP2076532B1 (de) 2010-12-01
HRP20110146T1 (hr) 2011-06-30
GB0614755D0 (en) 2006-09-06
SI2076532T1 (sl) 2011-06-30
HK1131162A1 (en) 2010-01-15
CA2658806A1 (en) 2008-01-31
KR101530353B1 (ko) 2015-06-26
CY1111630T1 (el) 2015-10-07
PL2076532T3 (pl) 2011-07-29
AU2007278894A1 (en) 2008-01-31
RS51854B (en) 2012-02-29
RU2009106436A (ru) 2010-08-27
BRPI0715331B8 (pt) 2021-05-25
CA2658806C (en) 2017-01-03
ZA200901342B (en) 2010-11-24
KR20090060281A (ko) 2009-06-11

Similar Documents

Publication Publication Date Title
NZ600731A (en) Oxyntomodulin peptide analogue
NZ600690A (en) Fkbp-l and uses thereof
IN2014CN02050A (de)
NZ627111A (en) Variants of activin iib receptor polypeptides and uses thereof
NZ600732A (en) Oxyntomodulin peptide analogue
EA201170878A1 (ru) Полипептиды с ксиланазной активностью
MX2008009493A (es) Peptido novedoso y uso del mismo.
WO2005068494A3 (en) Chimera botulinum toxin type e
ATE417595T1 (de) Keratin-bindende polypeptide
NO20063026L (no) Antistoffer
NZ593550A (en) ANTI-Siglec-15 ANTIBODY
EA201170879A1 (ru) Полипептиды с ксиланазной активностью
NZ591612A (en) Prevention, treatment and diagnosis of p.gingivalis infection with peptides
NZ609216A (en) Anticancer fusion protein
DE602007004110D1 (de) Hausstaubmilbenallergen
WO2010007144A3 (en) Mutated netrin-4 proteins, fragments thereof and their uses as drugs
WO2008113536A8 (en) Neurotrophic peptides
WO2007142582A8 (en) Fluorescent proteins and genes encoding them
NZ601647A (en) Variant hhip1 protein and methods and uses thereof
WO2006097432A3 (de) Keratin-biktdende desmoplakinpolypeptidsequenzen
DE602007010969D1 (de) Zytokinderivate
ATE441865T1 (de) Neue polypeptide zur in-vintro-isolierung und vorbeugung von infektionen mit legionella pneumophila
MY150639A (en) T cell adhesion molecule and antibody thereto
WO2006123157A3 (en) Nematistatic protein
DE602005018369D1 (de) Neue proteine, z.b. zur verwendung für die in-vitro-isolierung und prävention von legionella pneumophila-infektionen